The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 211,714 | 3,700 | SH | SOLE | 3,700 | 0 | 0 | ||
| MICRON TECHNOLOGY INC | COM | 595112103 | 542,516 | 470 | SH | SOLE | 470 | 0 | 0 | ||
| CELLEBRITE DI LTD | ORDINARY SHARES | M2197Q107 | 1,095,000 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| NASDAQ INC | COM | 631103108 | 4,606,178,375 | 58,439,208 | SH | SOLE | 58,439,208 | 0 | 0 | ||
| MEDIWOUND LTD | SHS NEW | M68830112 | 12,819,767 | 872,093 | SH | SOLE | 872,093 | 0 | 0 | ||
| ASTRAZENECA PLC | ORD | G0593M107 | 9,782,080,532 | 51,587,810 | SH | SOLE | 51,587,810 | 0 | 0 | ||
| VERIZON COMMUNICATIONS INC | COM | 92343V104 | 478,442 | 11,300 | SH | SOLE | 11,300 | 0 | 0 | ||